Drug Profile
Research programme: vestibular disorder therapeutics - Griffin Discoveries/Sensorion
Alternative Names: H4R antagonist - Griffin DiscoveriesLatest Information Update: 28 Jul 2018
Price :
$50
*
At a glance
- Originator Griffin Discoveries; Sensorion
- Class
- Mechanism of Action Histamine H4 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Ear disorders
Most Recent Events
- 28 Jul 2018 No recent reports of development identified for research development in Ear disorders in European Union
- 19 Jul 2016 Early research is still underway in the European Union